Stanford University
Showing 6,001-6,050 of 34,900 Results
-
Lorna Corbetta
Evening Supervisor & Head of Reserves, Art and Architecture Library
BioAs Evening Supervisor, I oversee the hiring, training, and supervision of the dozen or so students who work for the library. In addition, I manage all the Course Reserves for art and architecture classes. I also maintain and prepare all Bowes special collections (Art Locked Stacks)
-
Roxanne Corbin
Marketing and Advertising Manager, Stanford Live
Current Role at StanfordMarketing and Advertising Manager
-
Kate Corcoran, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Corcoran is a Clinical Professor in the Department of Psychiatry and Behavioral Sciences, where she is actively involved in teaching psychotherapy to graduate students, psychiatry residents, and postdoctoral fellows. She is the Curriculum Director of CBT Training for the Psychiatry Residency program, and she teaches CBT to first year graduate students in the Psy.D. Consortium program. She is also a supervisor in the ADAPT Clinic, where she supervises postdoctoral fellows and PGY3 residents in the provision of CBT. In her clinical practice, Dr. Corcoran specializes in cognitive-behavioral therapy (CBT), mindfulness-based interventions, and compassion-focused approaches for adults experiencing anxiety, stress, and depression.
-
Amy Cordones-Hahn
Lead Scientist, Energy Sciences
BioI am a staff scientist in the Stanford PULSE Institute at SLAC National Accelerator Laboratory, where I work in the Solution Phase Chemistry Group. I am interested in understanding the excited state processes that drive photochemical reactions of transition metal complexes relevant for solar energy conversion and catalysis. My research takes advantage of the atomic specificity of ultrafast x-ray methods at the Linac Coherent Light Source (LCLS), coupled with complementary ultrafast optical spectroscopy methods, to resolve the dynamics and reaction mechanisms of transition metal complexes acting as photosensitizers and photocatalysts.
Research website: https://ultrafast.stanford.edu/solution-phase-chemistry-group-pulse -
Linda C. Cork, DVM, PhD
Professor of Comparative Medicine, Emerita
Current Research and Scholarly InterestsDr. Linda Cork is Professor Emerita and former department chair. Her research focused on the identification and characterization of animal models of human neurodegenerative diseases. Dr. Cork no longer accepts students for mentoring.
-
Tyler Edward Cork
Postdoctoral Scholar, Radiological Sciences Laboratory
Current Research and Scholarly InterestsCurrently, I am involved in two main projects. The first is developing 3D printing techniques to improve the accuracy of ex vivo geometrical and microstructural cardiac modeling from in vivo cardiac MR acquisitions. The second is applying machine learning applications to MRI data as a way to improve overall image quality and reduce acquisition time.
-
Joanne Cornbleet
Associate Professor of Pathology at the Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsAs medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases.
-
David N. Cornfield
Anne T. and Robert M. Bass Professor of Pediatric Pulmonary Medicine
Current Research and Scholarly InterestsOver the past 20 years, the Cornfield Laboratory has focused upon basic, translational and clinical research, with a primary focus on lung biology. As an active clinician-scientist, delivering care to acutely and chronically ill infants and children, our lab focuses on significant clinical challenges and tried to use science to craft novel solutions to difficult clinical problems.
-
Steven M. Corsello
Assistant Professor of Medicine (Oncology) and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur laboratory operates at the intersection of functional genomics and chemical biology, with the goal of advancing novel molecular mechanisms of cancer inhibition to clinical use. We aim to 1) leverage phenotypic screening and functional genomics to determine novel anti-cancer mechanisms of small molecules, 2) develop new targeted therapy approaches against solid tumors, and 3) build a comprehensive community resource for drug repurposing discovery.
